Brief: Cantargia Publishes New Data On Can10 Antibody
17/04/2024 16:03
April 17 (Reuters) - Cantargia AB CANTA.ST :
* PUBLISHES NEW DATA ON THE CAN10 ANTIBODY, DETAILING ITS INTERACTION WITH IL1RAP AND
FUNCTIONAL
INHIBITION
* NEW PRECLINICAL DATA SPECIFYING PRECISE INTERACTIONS BETWEEN CAN10 AND ITS TARGET IL1RAP
* DATA ALSO HIGHLIGHTING ITS FUNCTIONAL CAPABILITIES TO BLOCK MULTIPLE SIGNALING PATHWAYS
Source text for Eikon: ID:nMFN2zZxy4
Further company coverage: CANTA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cantargia AB
See all newsBrief: Cantargia Publishes Nadunolimab CANFOUR Study Data
Brief: Cantargia Announces Outcome Of Rights Issue, Raising About SEK 75 Mln
Brief: Cantargia Carries Out Rights Issue, Enters Loan Agreement
Brief: Cantargia Q1 Operating Loss Narrows To SEK 36.9 Mln
Brief: Cantargia: Early Results From Phase 1B/2A Nadunolimab Trial In MDS And AML